Time to give Horizon Pharma PLC (NASDAQ:HZNP) a wide berth?


Horizon Pharma Public Limited Company (NASDAQ:HZNP), whose P/Free Cash Flow calculates to 7.11.

The company reported EPS of $-1.04 in the last fiscal year. Its next earnings report is expected on Earnings Date May 08/b.

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

Horizon Pharma plc HZNP is scheduled to report first-quarter 2017 results before the opening bell on May 8.

Horizon’s performance has been dismal with the company missing earnings estimates in the four trailing quarters. Overall, the company has an average negative earnings surprise of 11.6%.

Last quarter, the company missed expectations by 3.8%.

For this year, EPS is expected to improve -509.50%% over the previous year?s EPS. The company has seen its EPS move EPS growth past 5 years 39.30%% over the last five years, and for the next five years EPS movement is expected to be 12.90%%.

What value is Horizon Pharma Public Limited Company generating for shareholders? The company’s return on assets for the trailing 12 months calculates to -4.70%%, return investments for the same period comes to -2.80%% and return on equity comes to -12.70%%.

Can Horizon Pharma Public Limited Company cope with its near-term financial needs to continue generating value for shareholders. A look at the company?s liquidity ratio shows it has current ratio of 1.70. For perspective, current ratio above 2 is considered healthy for a company as it implies the company can meet its near-term financial needs. Horizon Pharma Public Limited Company?s quick ratio on the other hand comes to 1.40. Once again, quick ratio of at least 1 is considered healthy for a company and quick ratio below 1 can be toxic to a company’s future.

As for other ratios worth keeping in mind, Horizon Pharma Public Limited Company’s Long Term Debt/Equity is 1.42 and Total Debt/Equity is 1.43.

Horizon Pharma Public Limited Company has mixed ownership if that means participation of insiders and outside institutional investors in the stock. Insider ownership of the company is 0.60% while institutional ownership is 90.10%. The company has seen -3.18% and 0.36% institutional transactions over the last couple of months.

Investors would do well to remember that of Horizon Pharma Public Limited Company’s 161.38M outstanding shares, 161.02M are free float. Of the floating shares, short float is 7.66%, which calculates to short ratio of 4.65.